SM
Subhashini Muddana
About Subhashini Muddana
Data last updated:
Subhashini Muddana is a Director at Puritan Labs Private Limited (since 2020) and Director at Ambesten Pharmaceuticals Private Limited (since 2015). The companies operate in Travel and Hospitality and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹8.08 Cr; the largest is Puritan Labs Private Limited at ₹8.08 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Mar 2020 | 2017 | ₹8.08 Cr (FY 2020) | Active | |
| Director | 03 Dec 2015 | 2015 | ₹7,196 (FY 2025) | Active |
Board colleagues of Subhashini Muddana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prasada Rao Gollapudi | 07186666 | Puritan Labs Private Limited , Ambesten Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhashini Muddana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhashini Muddana
Subhashini Muddana currently holds 2 directorships: Puritan Labs Private Limited (Director, since 02 Mar 2020, revenue ₹8.08 Cr (FY 2020)); Ambesten Pharmaceuticals Private Limited (Director, since 03 Dec 2015, revenue ₹7,196 (FY 2025)).
Subhashini Muddana was first appointed on 03 Dec 2015 as Director at Ambesten Pharmaceuticals Private Limited. The most recent appointment on record is 02 Mar 2020 at Puritan Labs Private Limited.
The 2 current companies of Subhashini Muddana that report revenue have a combined latest revenue of ₹8.08 Cr: Puritan Labs Private Limited ₹8.08 Cr (FY 2020); Ambesten Pharmaceuticals Private Limited ₹7,196 (FY 2025).
The current boards of Subhashini Muddana's companies include Prasada Rao Gollapudi (Puritan Labs Private Limited).